<- Go Home
DexCom, Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$33.1B
Volume
4.0M
Cash and Equivalents
$621.2M
EBITDA
$840.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.4B
Profit Margin
61.68%
52 Week High
$142.00
52 Week Low
$62.34
Dividend
N/A
Price / Book Value
16.75
Price / Earnings
50.88
Price / Tangible Book Value
17.92
Enterprise Value
$33.2B
Enterprise Value / EBITDA
38.04
Operating Income
$628.0M
Return on Equity
32.06%
Return on Assets
6.06
Cash and Short Term Investments
$2.5B
Debt
$2.6B
Equity
$2.0B
Revenue
$4.0B
Unlevered FCF
$365.1M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium